GPIIb/IIIa receptor inhibitor (Capital Medical University)

N/A

Report date: 2025/03/20 15:28:09
NME

Base Information

Drug NameGPIIb/IIIa receptor inhibitor (Capital Medical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor inhibitorsIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3Coagulation factor
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCapital Medical University
China Registration ClassN/A

Develop Information

Active CompaniesCapital Medical University
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A